Johnson & Johnson $98.75

down -0.45


16/4/2014 04:15 PM  |  NYSE : JNJ  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get JNJ Trend Analysis - it has outperformed the S&P 500 by 3%

Partner Headlines

  1. UPDATE: Bank of America Reiterates on Johnson & Johnson Following Strong ...

    Benzinga
  2. UPDATE: Deutsche Bank Reiterates on Johnson & Johnson as Defensive Stock

    Benzinga
  3. #PreMarket Primer: Wednesday, April 16: Chinese GDP Slows, But Surpasses ...

    Benzinga
  4. J&J Gains On Modest Q1 Beat

    IBD
  5. If Airbnb’s Worth $10B, HomeAway’s A Bargain

    YCharts
  6. Mid-Afternoon Market Update: Markets Trade in Highly Volatile Session as ...

    Benzinga
  7. Mid-Day Market Update: US Stocks Turn Red; Pep Boys Shares Drop After Q4 ...

    Benzinga
  8. The Market Is Not Acting Right

    Benzinga
  9. J&J Earnings Beat Estimates As Pharma Sales Shine

    IBD
  10. Mid-Morning Market Update: Markets Gain; Johnson & Johnson Profit Beats ...

    Benzinga
  11. Stock Futures Firmly Higher; Zebra, Coca-Cola, J&J Surge

    IBD
  12. UPDATE: Johnson & Johnson Posts Upbeat Q1 Earnings, Lifts FY14 Outlook

    Benzinga
  13. J&J Tops Street Views Amid Strong Drug Sales

    FoxBusiness
  14. Stock Futures Tick Up Amid Upbeat Earnings

    FoxBusiness
  15. Strong Corporate Earnings Lift Wall Street

    FoxBusiness
  16. ETF Outlook for Tuesday, April 15, 2014 (EWH, FCG, PSP, HDV)

    Benzinga
  17. #PreMarket Primer: Tuesday, April 15: Hopes For Diplomacy In Ukraine Help ...

    Benzinga
  18. Earnings Scheduled For April 15, 2014

    Benzinga
  19. Stocks To Watch For April 15, 2014

    Benzinga
  20. #PreMarket Primer: Monday, April 14: Military Action In Ukraine Looking ...

    Benzinga
  21. 4 Top Stocks in the Medical Device Sector

    GuruFocus
  22. Benzinga Weekly Preview: Short, But Action Packed Week Ahead

    Benzinga
  23. Week Ahead: Loads of Bank Earnings

    FoxBusiness
  24. Top 40 Upcoming Earnings Releases

    Benzinga
  25. ADP's

    IBD
  26. #PreMarket Primer: Thursday, April 10: Job Creation Will Be China's Main ...

    Benzinga
  27. #PreMarket Primer: Wednesday, April 9: John Kerry Accuses Russia Of Stirring ...

    Benzinga
  28. Alkermes' Schizophrenia Drug Passes Trial; Filing In Q3

    IBD
  29. Is The Market Still Playing Defense?

    Benzinga
  30. Nasdaq Slumps 2.6%; Growth Stocks Bear Brunt Of Selling

    IBD
  31. Growth Names Pressured; Nasdaq Gives Up 50-Day Line

    IBD
  32. Is Dividend Machine JNJ a Buy?

    GuruFocus
  33. J&J, Carlyle in $4 bil unit sale

    IBD
  34. Benzinga's M&A Chatter for Monday March 31, 2014

    Benzinga
  35. Market Wrap For March 31: Stocks Rally As Yellen Confirms Support For Economy

    Benzinga
  36. Weekly 52-Week Highs Highlight: MAR, JNJ, HAL, BHI

    GuruFocus
  37. Stocks Rising In Soft Trade; GE, Intel, J&J Advancing

    IBD
  38. Stocks Hitting 52-Week Highs

    Benzinga
  39. J&J Agrees to Sell Ortho Arm to Carlyle for $4B

    FoxBusiness
  40. UPDATE: J&J Announces Acceptance of Binding Offer from Carlyle Group to ...

    Benzinga
  41. Johnson Controls: Back to Consistency?

    GuruFocus
  42. ETFs Shrugging Off The Selling (DHS, SMH, IGF, INTC)

    Benzinga
  43. Dow Chemical Benefits From 'Flight to Quality' Trade

    IBD
  44. Sanofi's Getting Back in the Game

    GuruFocus
  45. Depomed A 'Turtle' Gaining In Specialty Pharma Race

    IBD
  46. Stocks Hitting 52-Week Highs

    Benzinga
  47. Which Pharmas Can Keep Up Dividend-Buybacks?

    YCharts
  48. Google Honors Activist Dorothy Height & Her Contributions

    Benzinga
  49. Biotechs, Medicals Get Hurt Amid Price-Inquiry News

    IBD
  50. Court overturns J&J ruling

    IBD
Trading Center